Works matching IS 17597706 AND DT 2020 AND VI 11 AND IP 12
Results: 33
CORRIGENDUM.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3645, doi. 10.1111/1759-7714.13747
- Publication type:
- Article
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3585, doi. 10.1111/1759-7714.13721
- By:
- Publication type:
- Article
Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3625, doi. 10.1111/1759-7714.13716
- By:
- Publication type:
- Article
Bilateral synchronous tonsillar metastasis from a mixed form of neuroendocrine tumor in the lung: Case report and literature review.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3622, doi. 10.1111/1759-7714.13714
- By:
- Publication type:
- Article
Clinical outcomes of pembrolizumab therapy in advanced‐NSCLC patients with poor performance status (≥3) and high PD‐L1 expression (TPS ≥50%): A case series.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3618, doi. 10.1111/1759-7714.13713
- By:
- Publication type:
- Article
Intraoperative diagnosis of lymph node metastasis during segmentectomy for non‐small cell lung cancer by rapid immunohistochemistry using noncontact alternating current electric field mixing.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3547, doi. 10.1111/1759-7714.13699
- By:
- Publication type:
- Article
Myositis induced by durvalumab in a patient with non‐small cell lung cancer: A case report.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3614, doi. 10.1111/1759-7714.13709
- By:
- Publication type:
- Article
Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3576, doi. 10.1111/1759-7714.13703
- By:
- Publication type:
- Article
Prognostic impact of micropapillary component in patients with node‐negative subcentimeter lung adenocarcinoma: A Chinese cohort study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3566, doi. 10.1111/1759-7714.13702
- By:
- Publication type:
- Article
Clinical T category for lung cancer staging: A pragmatic approach for real‐world practice.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3555, doi. 10.1111/1759-7714.13701
- By:
- Publication type:
- Article
Primary thymic adenocarcinoma with an aggressive clinical course: An autopsy case showing signet ring cell‐like features.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3609, doi. 10.1111/1759-7714.13700
- By:
- Publication type:
- Article
Echoendoscopic appearance of mediastinal metastasis from papillary renal carcinoma.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3631, doi. 10.1111/1759-7714.13704
- By:
- Publication type:
- Article
Efficacy and safety of PD‐1/PD‐L1 inhibitor plus chemotherapy versus chemotherapy alone as first‐line treatment for extensive‐stage small cell lung cancer: A systematic review and meta‐analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3536, doi. 10.1111/1759-7714.13698
- By:
- Publication type:
- Article
Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3605, doi. 10.1111/1759-7714.13697
- By:
- Publication type:
- Article
Contralateral pulmonary resection using selective bronchial blockade in postpneumonectomy patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3528, doi. 10.1111/1759-7714.13696
- By:
- Publication type:
- Article
Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3521, doi. 10.1111/1759-7714.13695
- By:
- Publication type:
- Article
Lung adenocarcinoma in a patient with a cis EGFR L858R‐K860I doublet mutation identified using NGS‐based profiling test: Negative diagnosis on initial companion test and successful treatment with osimertinib.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3599, doi. 10.1111/1759-7714.13694
- By:
- Publication type:
- Article
LncRNA SNHG20 promoted proliferation, invasion and inhibited cell apoptosis of lung adenocarcinoma via sponging miR‐342 and upregulating DDX49.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3510, doi. 10.1111/1759-7714.13693
- By:
- Publication type:
- Article
Distal‐type bronchiolar adenoma of the lung harboring an EGFR exon 21 p.L858R mutation: A case report.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3596, doi. 10.1111/1759-7714.13692
- By:
- Publication type:
- Article
Blocking leptin‐STAT3 axis‐induced fatty acid oxidation: A novel approach to activate CD8<sup>+</sup> T effector cells in breast cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3422, doi. 10.1111/1759-7714.13691
- By:
- Publication type:
- Article
Safety and efficacy of tislelizumab plus chemotherapy for first‐line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3419, doi. 10.1111/1759-7714.13690
- By:
- Publication type:
- Article
Superior efficacy of immunotherapy‐based combinations over monotherapy for EGFR‐mutant non‐small cell lung cancer acquired resistance to EGFR‐TKIs.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3501, doi. 10.1111/1759-7714.13689
- By:
- Publication type:
- Article
Ratio between negative and positive lymph nodes is a novel prognostic indicator for patients with esophageal cancer: A Surveillance, Epidemiology and End Results database analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3490, doi. 10.1111/1759-7714.13688
- By:
- Publication type:
- Article
Preoperative mediastinal staging in patients with cT1‐3NxM0 non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3456, doi. 10.1111/1759-7714.13673
- By:
- Publication type:
- Article
Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3482, doi. 10.1111/1759-7714.13684
- By:
- Publication type:
- Article
Genetic variants as predictors of toxicity and response in patients with non‐small cell lung cancer undergoing first‐line platinum‐based chemotherapy: Design of the multicenter PGxLUNG study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3634, doi. 10.1111/1759-7714.13683
- By:
- Publication type:
- Article
MiR‐133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF‐β/Smad3 signaling pathway.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3473, doi. 10.1111/1759-7714.13678
- By:
- Publication type:
- Article
Invasive mucinous adenocarcinoma of the lung: Serial CT findings, clinical features, and treatment and survival outcomes.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3463, doi. 10.1111/1759-7714.13674
- By:
- Publication type:
- Article
Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first‐line chemotherapy: A multicenter prospective cohort study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3641, doi. 10.1111/1759-7714.13687
- By:
- Publication type:
- Article
Locoregional control and toxicity after pleurectomy/decortication and intensity‐modulated pleural radiation therapy in patients with malignant pleural mesothelioma.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3448, doi. 10.1111/1759-7714.13668
- By:
- Publication type:
- Article
Serum exosomal miR‐1269a serves as a diagnostic marker and plays an oncogenic role in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3436, doi. 10.1111/1759-7714.13644
- By:
- Publication type:
- Article
KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC).
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3425, doi. 10.1111/1759-7714.13538
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3417, doi. 10.1111/1759-7714.13119
- Publication type:
- Article